You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

idarucizumab

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idarucizumab in Pediatric Patients

Withdrawn
  • Hemorrhage
  • idarucizumab
  • (no location specified)
Nov 11, 2021

Japanese Pradaxa PMS, Long Term

Completed
Has Results
  • Atrial Fibrillation
  • Prazaxa® Capsules
  • Tokyo, Japan
    Nippon Boehringer Ingelheim Co., Ltd
Feb 3, 2022

Registration of Idarucizumab for IntraCranial Hemorrhage

Completed
  • Intracranial Hemorrhage
  • Dabigatran Etexilate Oral Capsule [Pradaxa]
  • +2 more
  • Bad Aibling, Germany
  • +32 more
Apr 6, 2022

All-Case Surveillance of Prizbind®

Completed
Has Results
  • Hemorrhage
  • Multiple Locations, Japan
    (unnamed)
Nov 2, 2021

Hemorrhage Trial in Kazan, Tyumen (Idarucizumab)

Completed
Has Results
  • Hemorrhage
  • Idarucizumab
  • Kazan, Russian Federation
  • +1 more
Mar 31, 2020

Healthy Volunteers Trial in Beijing (Dabigatran etexilate, Idarucizumab)

Completed
Has Results
  • Healthy Volunteers
  • Dabigatran etexilate
  • Idarucizumab
  • Beijing, China
    Peking University First Hospital
Mar 7, 2019

Urin-based Point-of-Care Testing for Direct Oral Anticoagulants

Recruiting
  • Stroke
  • Urin-based test by the DOASENSE Dipstick Device
  • Gießen, Hesse, Germany
    Department of Neurology, University Hospital Giessen
Sep 13, 2023

Medical Need of OAC Reversal

Completed
Has Results
  • Atrial Fibrillation
  • Tokyo, Japan
    Nippon Boehringer Ingelheim Co., Ltd.
Oct 31, 2018

Hemorrhage Trial in Fukuoka, Kasuga (idarucizumab)

Completed
Has Results
  • Hemorrhage
  • idarucizumab
  • Fukuoka, Kasuga, Japan
    Fukuoka Tokushukai Medical Center
Mar 19, 2018

Severe Bleeding, Urgent Surgery Trial (Urgent surgery which can not be postponed to the next 24 hrs)

Withdrawn
  • Severe Bleeding
  • Urgent Surgery
  • Urgent surgery which can not be postponed to the next 24 hrs
  • (no location specified)
Jul 15, 2020

Atrial Fibrillation, Venous Thromboembolism, Arterial Vascular Disease Trial in Hamilton

Unknown status
  • Atrial Fibrillation
  • +2 more
    • Hamilton, Ontario, Canada
    • +2 more
    Dec 17, 2019

    Hemorrhage Trial in Worldwide (idarucizumab)

    Completed
    Has Results
    • Hemorrhage
    • idarucizumab
    • Little Rock, Arkansas
    • +175 more
    Jan 3, 2018

    Blood Coagulation Trial in United States (mgt of bleeding concerns/complications of oral anticoagulants)

    Unknown status
    • Blood Coagulation
    • mgt of bleeding concerns/complications of oral anticoagulants
    • Birmingham, Alabama
    • +8 more
    May 20, 2018

    Healthy Trial in Sumida-ku, Tokyo (Placebo to dose, Idarucizumab, Placebo to Idarucizumab)

    Completed
    Has Results
    • Healthy
    • Placebo to dose
    • +3 more
    • Sumida-ku, Tokyo, Japan
      1321.5.00001 Boehringer Ingelheim Investigational Site
    Jan 13, 2016

    Healthy Trial in Antwerpen (Dabigatran, BI 655075, Placebo)

    Completed
    Has Results
    • Healthy
    • Antwerpen, Belgium
      1321.1.1 Boehringer Ingelheim Investigational Site
    May 20, 2016

    Hemorrhage Trial in Antwerpen (BI 655075, Placebo)

    Completed
    Has Results
    • Hemorrhage
    • BI 655075
    • Placebo
    • Antwerpen, Belgium
      1321.2.1 Boehringer Ingelheim Investigational Site
    Jan 13, 2016